Galectin Therapeutics
1 follower
‌
Galectin Therapeutics (NASDAQ: GALT) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Company’s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pat... Read more
Industries
Headquarters
Employees
Links
Org chart
Joel Lewis
CEO & President
Joel Lewis
Collapse
Susan Thornton
VP, Regulatory Affairs
Ezra R. Lowe
VP, Clinical & Preclinical Pharmacology
Jeff Katstra
Head of CMC & Pharmaceutical Development
Sharisse Brutto
Director, Project Management
Seth Zuckerman
Senior Director, Biostatistics
Marla Mills-Wilson
Executive Director, Clinical Operations
Similar companies
Charlie Health
5 followers
VistaGen Therapeutics
3 followers
Biotrial Inc.
1 follower
Bristol-Myers Squibb
165 followers
Walgreens Boots Alliance
103 followers
Syneos Health
16 followers
NYU Langone Health
12 followers
Organon
10 followers
PCI Pharma Services
6 followers
DispatchHealth
6 followers
vTv Therapeutics
1 follower
Discover companies